Good MorningEquities rebounded again on Thursday but there is a growing list of companies giving reasons why the rally shouldn't be trusted. The key takeaways from earnings reports this weak are that near-term headwinds are growing because of the Ukrainian conflict and they may worsen as the war wears on. Not only is the conflict causing a spike in energy prices but it is also putting a strain on an already struggling supply chain. What this means for S&P 500 companies is a negative impact to the top and bottom line, declining expectations for revenue and earnings, and lower prices for the S&P 500 index.
Friday's market action will be driven by geopolitical sentiment and Fedspeak. There are at least 4 Fed members on the schedule to make remarks and each will be closely watched for clues about interest rates. Fed chief Jerome Powell surprised the market earlier in the week when he gave a more hawkish opinion of the inflation outlook than what was expected and now the market is pricing in a 50 basis point hike at the next FOMC meeting. Featured: Elon’s big $266,000 per second purchase (Ad) 
|
Auto/Tires/Trucks | |
This might not be a question you were expecting to hear with regards to NIO (NYSE: NIO), whose shares are down almost 70% from last year’s all-time high, but it’s one worth asking. Because if one thing’s for sure, the Shanghai headquartered electric vehicle (EV) maker knows how t... Read the Full Story |
|
From Our Partners | | Bill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97.
It's a single-page, seven-point filter designed to help traders identify weak setups before placing any options trade. Print it, keep it at your desk, and run it before every trade. The download link expires soon. | | Download your free copy of the Smart Trade Options Checklist now |
|
Retail/Wholesale | |
Darden Restaurants International Is Another Reason Not To Trust The Rally
Darden Restaurants (NYSE: DRI) gave the market another reason not to trust the rebound in equities when it reported earnings. The company not only missed on the top and bottom lines but tightened its guidance to a range be... Read the Full Story |
|
Consumer Staples | |
But wait for confirmation before going on the long side of OLLI stock
Ollie’s Bargain Outlet Holdings (NASDAQ: OLLI) delivered another disappointing earnings report. However, investors may be signaling that the sell-off of OLLI stock is overdone. The stock price has been consolidating in t... Read the Full Story |
|
From Our Partners | | Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security.
The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move. | | Watch the documentary briefing and find out which side you land on |
|
Energy | | What to do when eastern Europe suddenly erupts into violence? Griping about the cost of gasoline (has anyone else shifted to filling up when the tank is half full?) has its cathartic moments, but it's also important to remember that whole countries are living in fear right now.
Even so, beyond dona... Read the Full Story |
|
Medical | |
There will always be a need for healthcare. Doctor visits, prescriptions, medical equipment, and of course, vaccines will remain fixtures in our society for decades to come.
This is what makes the defensive healthcare sector a good place to park funds for the long-term. Regardless of the economi... Read the Full Story |
|
From Our Partners | | Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now.
Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen.
Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch. | | Watch how to access the legal backdoor before it closes. |
|
Markets | | 3D printing and digital manufacturing solutions provider 3D Systems (NASDAQ: DDD) stock has sold-off over (-60%) from its pandemic high of $56.50. The maker of 3D printing systems has seen growing mainstream adaption of the technology from the aerospace, automotive, electronics, manufacturing, indus... Read the Full Story |
|
Markets | | Gaming technology services and products maker International Gaming Technology (NYSE: IGT) stock has held up relatively well in 2022 despite the benchmark indices sell-off. While the Omicron variant impacted some markets with labor shortages, supply chain pressures and cost inflation, IGT still manag... Read the Full Story |
|
Business Services | |
Factset Research Systems Slips On Solid Results
The price action in Factset Research Systems (NYSE: FDS) underwent a correction over the past few months but it looks like that time is now behind us. The correction was due to uncertainty over the future, uncertainty over acquisition, and no small... Read the Full Story |
|
Basic Materials | |
H.B. Fuller Seals The Deal On Inflation
If you were worried about inflation taming in the second half of the year H.B. Fuller (NYSE: FUL) has laid those fear to rest. The report from H.B. Fuller, a manufacturer of specialty adhesive chemicals worldwide, guarantees input costs are going to go up ... Read the Full Story |
|
Technology | |
These 3 Semi Stocks Should Be On Your Radar
Finding valid reasons to invest in semiconductor stocks is certainly not difficult. These tiny chips are critical for powering up some of the most exciting technology today, including smartphones, data centers, and even electric vehicles. Then you have ... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States and internationally. The company offers JAKAFI (ruxolitinib) for treatment of intermediate or high-risk myelofibrosis, polycythemia vera, and steroid-refractory acute graft-versus-host disease; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab) for relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in liquid and solid tumor types; ICLUSIG (ponatinib) to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; and ZYNYZ (retifanlimab-dlwr) to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma, as well as OPZELURA cream for treatment of atopic dermatitis. Its clinical stage products include retifanlimab under Phase 3 clinical trials for squamous cell carcinoma of the anal canal and non-small cell lung cancer; axatilimab, an anti-CSF-1R monoclonal antibody under Phase 2 that is being developed as a therapy for patients with chronic GVHD; INCA033989 to inhibit oncogenesis; INCB160058, which is being developed as a disease-modifying therapeutic; and INCB99280 and INCB99318 for the treatment solid tumors. The company also develops INCB123667, INCA32459, and INCA33890, as well as Ruxolitinib cream, Povorcitinib, and INCA034460. It has collaboration out-license agreements with Novartis and Lilly; in-license agreements with Agenus, Merus, MacroGenics, and Syndax; and collaboration and license agreement with China Medical System Holdings Limited for the development and commercialization of povorcitinib. The company sells its products to specialty, retail, and hospital pharmacies, distributors, and wholesalers. The company was formerly known as Incyte Genomics Inc and changed its name to Incyte Corporation in March 2003. Incyte Corporation was incorporated in 1991 and is headquartered in Wilmington, Delaware. | | View Today's Stock Pick |
|
